BPC-157 Protects Against Nitric Oxide-Related Tissue Damage

BPC-157 showed protective effects against tissue damage caused by both NO agonists and antagonists, suggesting it helps maintain balanced nitric oxide signaling.

Grabarevic, Z et al.·Journal of physiology·1997·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00409Animal StudyPreliminary Evidence1997RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

BPC-157 protected against lesions from both NO agonists and NO antagonists, suggesting a modulatory rather than one-directional effect on nitric oxide signaling.

Key Numbers

How They Did This

Broiler chicks pretreated with BPC-157 (10 µg/kg or 10 ng/kg IP) or saline before receiving NO agonists or antagonists. Tissue damage and pulmonary hypertension severity assessed.

Why This Research Matters

BPC-157's ability to protect against both excess and insufficient NO signaling suggests it acts as a system balancer — a unique property that could explain its wide-ranging protective effects.

The Bigger Picture

This study revealed BPC-157's interaction with the nitric oxide system, one of the body's most important signaling pathways, potentially explaining its broad tissue-protective effects throughout the body.

What This Study Doesn't Tell Us

Animal study in chicks, a model primarily relevant to poultry pulmonary hypertension. Mechanism of NO modulation not fully elucidated.

Questions This Raises

  • ?Does BPC-157 modulate NO signaling in mammals similarly?
  • ?Is NO modulation the primary mechanism behind BPC-157's widespread protective effects?

Trust & Context

Key Stat:
Dual-direction NO protection BPC-157 protected against damage from both NO agonists and NO antagonists — a unique balancing action
Evidence Grade:
Preliminary animal evidence in a poultry model. Demonstrates the principle of NO modulation but limited translational relevance to humans.
Study Age:
Published in 1997, this was an early study linking BPC-157 to nitric oxide modulation — now considered a key part of its mechanism.
Original Title:
The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks.
Published In:
Journal of physiology, Paris, 91(3-5), 139-49 (1997)
Database ID:
RPEP-00409

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is nitric oxide's role in the body?

Nitric oxide (NO) is a signaling molecule that regulates blood vessel dilation, immune function, and tissue repair. Both too much and too little NO can cause damage, which is why BPC-157's ability to balance NO signaling is particularly interesting.

Why does BPC-157 protect against both excess and deficient NO?

BPC-157 appears to act as a modulator rather than a simple blocker or booster of NO. It may help maintain optimal NO levels, protecting when there's too much and supporting when there's too little.

Read More on RethinkPeptides

Cite This Study

RPEP-00409·https://rethinkpeptides.com/research/RPEP-00409

APA

Grabarevic, Z; Tisljar, M; Artukovic, B; Bratulic, M; Dzaja, P; Seiwerth, S; Sikiric, P; Peric, J; Geres, D; Kos, J. (1997). The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks.. Journal of physiology, Paris, 91(3-5), 139-49.

MLA

Grabarevic, Z, et al. "The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks.." Journal of physiology, 1997.

RethinkPeptides

RethinkPeptides Research Database. "The influence of BPC 157 on nitric oxide agonist and antagon..." RPEP-00409. Retrieved from https://rethinkpeptides.com/research/grabarevic-1997-the-influence-of-bpc

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.